MiniMed Group, Inc. (MMED)

Revenue

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Apr 24, 2026	Apr 25, 2025	Apr 26, 2024	Apr 28, 2023
Pumps Revenue	546.00M	541.00M
Pumps Revenue Growth	0.92%	0.18%
Consumables Revenue	956.00M	854.00M
Consumables Revenue Growth	11.94%	9.91%
Continuous Glucose Monitoring (CGM) Revenue	1.55B	1.31B
Continuous Glucose Monitoring (CGM) Revenue Growth	18.28%	17.55%
Other Segment Revenue	46.00M	6.00M
Other Segment Revenue Growth	666.67%	-82.35%
Revenue (Other)	1.00M	1.00M
Revenue (Total)	3.10B	2.72B
Revenue (Total) Growth	14.25%	9.96%

Revenue by Geography

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Apr 24, 2026	Apr 25, 2025	Apr 26, 2024	Apr 28, 2023
United States Revenue	917.00M	903.00M
United States Revenue Growth	1.55%	8.40%
International Revenue	2.19B	1.81B
International Revenue Growth	20.59%	10.76%
Revenue (Other)	-	-
Revenue (Total)	3.10B	2.72B
Revenue (Total) Growth	14.25%	9.96%

Key Performance Indicators

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Apr 24, 2026	Apr 25, 2025	Apr 26, 2024	Apr 28, 2023
US - Organic Revenue Growth	1.50%	8.40%
International - Organic Revenue Growth	11.20%	13.10%
Total Organic Revenue Growth	8.00%	11.50%

Data Source: Fiscal.ai Last updated: Jun 3, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 24, 2026

Data Sources Report a data error